Smerud Medical Research Denmark

What Smerud Medical Research Denmark does

Smerud Medical Research Denmark is the Danish subsidiary of Smerud Medical Research International AS, a privately held Norwegian full-service Contract Research Organisation (CRO) founded in 1990. Operating as part of a 7-country Northern European group (Norway HQ plus Denmark, Finland, Sweden, the United Kingdom, Germany, Austria, and Poland), the Danish entity provides local point-of-contact clinical trial services to biotech, pharmaceutical, med-tech, and academic sponsors. The subsidiary shares the parent's integrated service portfolio spanning Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, Medical Writing, Clinical Development Consulting, and Medical Device services.

The business is built on expertise-driven service delivery rather than proprietary technology: the company describes no platform or AI-based tooling, and competitive positioning rests on senior-level drug development talent, multi-jurisdictional regulatory knowledge, and a 33+ year track record of 900+ executed clinical trials across 75+ therapeutic areas including oncology, dermatology, cardiovascular, rare disorders, and medical devices. Revenue is generated through professional-services contracts (typically quote-based and negotiated per engagement), with services delivered by PhD-qualified medical writers, qualified persons for pharmacovigilance, and experienced clinical research physicians. The 1–10 employee headcount disclosed for the Danish entity indicates a lean local operation relying on group-level resourcing, with the broader group's go-to-market relying on direct enterprise engagement and professional-network business development rather than broad marketing or digital channels.

Name

Smerud Medical Research Denmark

Legal name

SMERUD MEDICAL RESEARCH INTERNATIONAL AS

Website

https://smerud.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

Smerud Medical Research Denmark is the Danish subsidiary of a privately held Norwegian full-service CRO, providing clinical trial, regulatory, biostatistics, and pharmacovigilance services to biotech, pharma, med-tech, and academic sponsors across Northern Europe.

Ownership category

akta.pro rank

Product category

Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Medical Writing & Clinical Documentation FSP (HLAGAOAC), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical trial services
• Contract research
• Regulatory affairs
• Pharmacovigilance services
• Biostatistics consulting

Headquarters

HQ city

Albertslund

HQ country

Denmark

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: Full-service CRO providing comprehensive clinical trial management including Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, Medical Writing, Clinical Development Consulting, and Medical Device services. Revenue is generated through service contracts with biotech, pharma, med-tech, and academic sponsors for conducting clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Smerud Medical Research Denmark is a regional subsidiary of Smerud Medical Research International AS operating as a full-service Contract Research Organisation (CRO). It delivers clinical trial services across eight integrated service lines — Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, Medical Writing, Clinical Development Consulting, and Medical Device services — for biotech, pharma, med-tech, and academic sponsors primarily in Northern Europe.

Product overview

Smerud Medical Research Group is a full-service Contract Research Organisation (CRO) providing a unified portfolio of clinical trial services to biotech, pharma, med-tech, and academic sponsors. The company operates as a single integrated service offering rather than a modular platform, with eight core service lines: Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, Medical Writing, Clinical Development Consulting, and Medical Device services. These services are delivered by highly educated specialists with senior-level expertise in drug development, primarily operating across Northern Europe with local presence in multiple countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Operations

Quantifiable outcome

• Over 900 successful Clinical Trials conducted in over 75 Therapeutic Areas

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Medpace: Mid-size full-service CRO focused on small and mid-sized biopharma sponsors with full-service clinical development; the closest size-segment comparable to Smerud and a direct competitor for the same customer profile.
• Worldwide Clinical Trials: Mid-size global CRO providing full-service clinical trial management with therapeutic specialisation; competes with Smerud in the mid-sized sponsor segment with overlapping Phase II-III capabilities.
• Cromsource: European-headquartered CRO providing clinical operations, resourcing, and full-service trial management; a directly comparable mid-size CRO with similar full-service offering and European geographic emphasis.
• TFS HealthScience: European-headquartered mid-size CRO providing clinical development, resourcing, and consulting services; the closest regional peer to Smerud with overlapping European sponsor base and full-service model.

Broad incumbents

• Charles River Laboratories: Global CRO and life sciences services provider offering clinical trial support alongside preclinical and laboratory services; comparable to Smerud as a research services provider serving biotech/pharma sponsors.
• Syneos Health: Global biopharmaceutical solutions organisation offering full-service clinical development and commercialisation; overlaps with Smerud's clinical operations and consulting services for pharma/biotech sponsors.
• ICON plc: One of the world's largest CROs offering full-service clinical development across all phases and geographies; comparable to Smerud as a full-service CRO competitor but with vastly greater scale and global reach.
• Parexel International: Major global CRO providing full-service clinical development, regulatory, and pharmacovigilance services; comparable to Smerud's service mix but with global Phase III scale and biopharmaceutical specialisation.
• IQVIA: Global CRO and life sciences technology leader providing clinical operations, biostatistics, and regulatory services; competes with Smerud on full-service CRO offerings but at a vastly larger scale and with proprietary technology assets.
• LabCorp (including Covance): Global CRO through its Covance Clinical Development & Commercialization Services unit, providing Phase I-IV clinical trial management and central laboratory services; overlaps with Smerud's clinical operations and data management offerings.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/smerud-medical-research-group

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smerud Medical Research Denmark